An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries. There might be a peripheral relevance to the group of our patients undergoing urgent surgical revascularisation after failed PCI: the balance of protecting the angioplasty versus minimising peri and postoperative heamorrhage is yet to be achieved.
You are here:
Aspirin-Free Strategies in ACS: Is It the Drug or the Stent?
Submitted by: Aristotle Protopapas
Source: JACC: Cardiovascular Interventions
Keywords:
Author(s): Michel Zeitouni Paul Guedeney
